What is the recommended medication and management plan for a patient 12 hours after lumbar facet ablation who is scheduled for sacrocolpopexy in 12 days?

Post-Ablation Pain Management Prior to Sacrocolpopexy

Continue multimodal non-opioid analgesia with scheduled NSAIDs and acetaminophen for the next 12 days, avoiding opioids unless absolutely necessary, as the lumbar facet ablation should provide adequate pain control and sacrocolpopexy typically requires only non-opioid analgesics postoperatively.

Immediate Post-Ablation Management (First 12 Days)

Pain Control Strategy

The 12-hour post-ablation timeframe places you at the peak pain period following radiofrequency ablation, which typically occurs on day 1 1. However, this procedural pain is self-limited and responds well to non-opioid medications.

Recommended regimen:

• NSAIDs (e.g., ibuprofen 400-600mg every 6-8 hours) - scheduled dosing, not as-needed
• Acetaminophen 1000mg every 6-8 hours - scheduled dosing
• Ice application to ablation site for first 48-72 hours
• Avoid opioids - the evidence shows non-opioid analgesics provide sufficient therapeutic effect 2

Key Clinical Considerations

Post-ablation pain trajectory: Maximum pain occurs on day 1 and decreases over the following 5 days 2. The ablation itself will provide therapeutic benefit for facet-mediated pain, with 53-58% of patients experiencing ≥50% pain improvement at long-term follow-up 3.

Medication continuation through surgery: According to SPAQI guidelines, NSAIDs and acetaminophen should be continued on the morning of surgery 4. This is critical - do not stop these medications before the sacrocolpopexy.

Pre-Sacrocolpopexy Preparation (Days 1-12)

Analgesic Optimization

Continue the multimodal regimen through day 12:

• NSAIDs provide anti-inflammatory benefits that may actually improve surgical outcomes
• Acetaminophen has no contraindications for continuation
• Both medications form the foundation of post-sacrocolpopexy pain management 2

What to Avoid

Do NOT initiate opioids during this bridge period unless pain is truly refractory to non-opioid therapy. The evidence is clear:

• 38% of sacrocolpopexy patients require no pain medication or only one dose 2
• Non-opioid analgesics should be preferred as first-line therapy 5
• Starting opioids now creates unnecessary perioperative complications and withdrawal risks

Do NOT stop NSAIDs preoperatively - this is a common pitfall. The SPAQI consensus explicitly recommends continuation 4, and sacrocolpopexy data supports non-opioid-based management 2.

Post-Sacrocolpopexy Pain Management (Day 12 Onward)

Expected Pain Profile

Laparoscopic sacrocolpopexy produces moderate postoperative pain with:

• Maximum severity on postoperative day 1
• Good response to NSAIDs
• Low prevalence of shoulder-tip pain (6.27%) 2
• Pain decreasing over 5-6 days

Medication Plan

Continue the same multimodal regimen:

• Scheduled NSAIDs and acetaminophen
• Add dexamethasone 4-8mg IV intraoperatively (standard multimodal protocol) 5
• Reserve short-acting opioids for breakthrough pain only, if needed 5, 6

If opioids become necessary:

• Use non-depot formulations only
• Titrate to effect in recovery
• Limit to "as needed" dosing for maximum few days 5
• Predictable benefit window exists before adverse effects dominate 6

Critical Pitfalls to Avoid

1. Stopping NSAIDs before surgery - contradicts current guidelines and worsens postoperative pain
2. Prophylactic opioid prescribing - unnecessary given the pain profile of both procedures
3. Assuming ablation pain requires opioids - it responds well to non-opioid therapy 1, 2
4. Discontinuing scheduled non-opioid medications - pain control requires consistent dosing, not PRN 5

Monitoring and Escalation

Contact surgeon if:

• Pain worsens or changes character (suggests complication, not expected post-procedural pain)
• New pain develops distinct from ablation site
• Pain persists beyond 3 months (becomes persistent pain requiring specialist assessment) 6

Expected timeline:

• Ablation pain: peaks day 1, resolves over 5 days
• Sacrocolpopexy pain: peaks postop day 1, resolves over 5-6 days
• Both procedures have overlapping recovery that supports non-opioid management

This approach prioritizes patient safety, minimizes opioid exposure, and aligns with the best available evidence showing excellent outcomes with multimodal non-opioid analgesia for both procedures 5, 2.